Simplex Trading, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 84,637 shares of LXRX stock, worth $135,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,637

Holding current value

$135,419

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$1.54 - $2.28 $130,340 - $192,972	84,637 New	84,637 $142,000
Q4 2023 Feb 02, 2024	BUY	$1.0 - $1.53 $54,248 - $82,999	54,248 New	54,248 $82,000
Q2 2023 Aug 04, 2023	SELL	$2.15 - $3.49 $53,100 - $86,196	-24,698 Reduced 54.13%	20,926 $47,000
Q1 2023 Apr 27, 2023	BUY	$1.99 - $2.68 $56,547 - $76,154	28,416 Added 165.13%	45,624 $110,000
Q4 2022 Feb 02, 2023	BUY	$1.8 - $2.56 $4,271 - $6,074	2,373 Added 16.0%	17,208 $32,000
Q3 2022 Nov 04, 2022	BUY	$1.94 - $3.43 $20,886 - $36,927	10,766 Added 264.59%	14,835 $35,000
Q2 2022 Aug 03, 2022	SELL	$1.31 - $2.69 $8,002 - $16,433	-6,109 Reduced 60.02%	4,069 $7,000
Q1 2022 May 02, 2022	SELL	$1.95 - $3.89 $72,085 - $143,801	-36,967 Reduced 78.41%	10,178 $21,000
Q4 2021 Feb 23, 2022	SELL	$3.81 - $6.16 $46,211 - $74,714	-12,129 Reduced 20.46%	47,145 $185,000
Q3 2021 Oct 28, 2021	SELL	$3.38 - $5.35 $37,649 - $59,593	-11,139 Reduced 15.82%	59,274 $258,000
Q2 2021 Aug 12, 2021	BUY	$4.12 - $5.87 $184,324 - $262,617	44,739 Added 174.26%	70,413 $323,000
Q1 2021 Apr 26, 2021	SELL	$3.45 - $9.09 $451,287 - $1.19 Million	-130,808 Reduced 83.59%	25,674 $0
Q4 2020 Feb 02, 2021	BUY	$1.05 - $3.67 $164,306 - $574,288	156,482 New	156,482 $535,000
Q3 2020 Oct 14, 2020	SELL	$1.44 - $2.1 $10,683 - $15,579	-7,419 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$1.75 - $2.3 $11,840 - $15,561	-6,766 Reduced 47.7%	7,419 $14,000
Q1 2020 Apr 29, 2020	BUY	$1.8 - $4.28 $12,229 - $29,078	6,794 Added 91.92%	14,185 $27,000
Q4 2019 Feb 05, 2020	BUY	$3.16 - $5.15 $23,355 - $38,063	7,391 New	7,391 $30,000
Q1 2019 Apr 18, 2019	SELL	$4.36 - $7.94 $255,434 - $465,172	-58,586 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$6.15 - $10.51 $280,790 - $479,855	45,657 Added 353.14%	58,586 $389,000
Q3 2018 Oct 23, 2018	BUY	$10.32 - $13.06 $132,302 - $167,429	12,820 Added 11761.47%	12,929 $137,000
Q2 2018 Jul 30, 2018	SELL	$7.8 - $13.69 $195 - $342	-25 Reduced 18.66%	109 $1,000
Q1 2018 Apr 26, 2018	SELL	$7.86 - $11.39 $3,599 - $5,216	-458 Reduced 77.36%	134 $1,000
Q4 2017 Jan 10, 2018	SELL	$8.77 - $12.28 $368,550 - $516,054	-42,024 Reduced 98.61%	592 $5,000
Q3 2017 Oct 25, 2017	BUY	$12.17 - $16.3 $518,636 - $694,640	42,616	42,616 $523,000

Others Institutions Holding LXRX

# of Institutions

131

Shares Held

240M

Call Options Held

617K

Put Options Held

286K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Lexicon Pharmaceuticals, Inc. Transaction History